Boston Scientific Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
ABTAbbott Laboratories -0.74%101.970.8%$708.30m
TMOThermo Fisher Scientific, Inc. -0.43%418.971.0%$615.44m
MDTMedtronic Plc -0.57%101.820.6%$507.34m
ISRGIntuitive Surgical, Inc. 0.86%663.082.4%$487.55m
DHRDanaher Corp. -0.57%204.030.7%$421.63m
BDXBecton, Dickinson & Co. -1.42%222.391.0%$409.93m
QDELQuidel Corp. -1.21%193.857.7%$398.52m
INOInovio Pharmaceuticals, Inc. -1.77%15.695.9%$378.87m
DXCMDexCom, Inc. -0.85%382.787.9%$302.38m
SYKStryker Corp. -1.00%200.381.3%$275.11m
BSXBoston Scientific Corp. -1.30%37.231.0%$272.71m
VARVarian Medical Systems, Inc. 0.19%172.139.1%$269.32m
BAXBaxter International, Inc. 1.00%79.111.8%$239.95m
ALGNAlign Technology, Inc. 2.36%315.606.4%$226.00m
EWEdwards Lifesciences Corp. -0.74%75.490.4%$216.94m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.